疫苗生产——第二届年度远景会议。

Idrugs Pub Date : 2010-07-01

Clifton McPherson

{"title":"疫苗生产——第二届年度远景会议。","authors":"Clifton McPherson","doi":"","DOIUrl":null,"url":null,"abstract":"The Vaccine Manufacturing--Second Annual visiongain Conference, held in London, included topics covering new technological developments in the field of influenza vaccine research. This conference report highlights selected presentations on influenza vaccine development in mammalian, insect and avian embryonic cells, regulatory considerations for cell culture-based influenza vaccine production, an improved animal model for influenza infection, and considerations for designing vaccine manufacturing facilities. Investigational drugs discussed include FluBiovax (Immunobiology Ltd) and FluBlok (Protein Sciences Corp/UMN Pharma Inc).","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"13 7","pages":"437-9"},"PeriodicalIF":0.0000,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vaccine Manufacturing--Second Annual visiongain Conference.\",\"authors\":\"Clifton McPherson\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Vaccine Manufacturing--Second Annual visiongain Conference, held in London, included topics covering new technological developments in the field of influenza vaccine research. This conference report highlights selected presentations on influenza vaccine development in mammalian, insect and avian embryonic cells, regulatory considerations for cell culture-based influenza vaccine production, an improved animal model for influenza infection, and considerations for designing vaccine manufacturing facilities. Investigational drugs discussed include FluBiovax (Immunobiology Ltd) and FluBlok (Protein Sciences Corp/UMN Pharma Inc).\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"13 7\",\"pages\":\"437-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在伦敦举行的疫苗生产——第二届年度展望会议的主题包括流感疫苗研究领域的新技术发展。本会议报告重点介绍了在哺乳动物、昆虫和禽类胚胎细胞中开发流感疫苗、基于细胞培养的流感疫苗生产的监管考虑、改进的流感感染动物模型以及设计疫苗生产设施的考虑等方面的精选报告。讨论的研究药物包括FluBiovax (Immunobiology Ltd)和FluBlok (Protein Sciences Corp/UMN Pharma Inc)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Vaccine Manufacturing--Second Annual visiongain Conference.

The Vaccine Manufacturing--Second Annual visiongain Conference, held in London, included topics covering new technological developments in the field of influenza vaccine research. This conference report highlights selected presentations on influenza vaccine development in mammalian, insect and avian embryonic cells, regulatory considerations for cell culture-based influenza vaccine production, an improved animal model for influenza infection, and considerations for designing vaccine manufacturing facilities. Investigational drugs discussed include FluBiovax (Immunobiology Ltd) and FluBlok (Protein Sciences Corp/UMN Pharma Inc).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Idrugs 医学-药学

自引率

0.00%

发文量

审稿时长

>12 weeks